Quarterly Report — Form 10-Q Filing Table of Contents
Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 1.63M
2: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 32K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 28K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 28K
12: R1 Document And Entity Information Document HTML 80K
13: R2 Consolidated Balance Sheets HTML 120K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 52K
15: R4 Consolidated Statements Of Income HTML 93K
16: R5 Consolidated Statements of Comprehensive Income HTML 52K
17: R6 Consolidated Statements Of Cash Flows HTML 122K
18: R7 Consolidated Statements Of Shareholders' Equity HTML 99K
19: R8 Organization HTML 32K
20: R9 Basis Of Presentation and Significant Accounting HTML 60K
Policies
21: R10 Business Acquisitions HTML 32K
22: R11 Business Optimization Initiatives HTML 30K
23: R12 Investments HTML 235K
24: R13 Derivative Financial Instruments Derivative HTML 31K
Financial Instruments
25: R14 Fair Value HTML 281K
26: R15 Income Taxes HTML 31K
27: R16 Retirement Benefits HTML 65K
28: R17 Medical Claims Payable HTML 136K
29: R18 Debt HTML 42K
30: R19 Commitments And Contingencies HTML 63K
31: R20 Capital Stock HTML 85K
32: R21 Accumulated Other Comprehensive Income HTML 83K
33: R22 Earnings Per Share HTML 39K
34: R23 Segment Information HTML 142K
35: R24 Leases HTML 65K
36: R25 Basis of Presentation and Significant Accounting HTML 76K
Policies (Policies)
37: R26 Investments (Tables) HTML 241K
38: R27 Fair Value (Tables) HTML 267K
39: R28 Retirement Benefits (Tables) HTML 65K
40: R29 Medical Claims Payable (Tables) HTML 136K
41: R30 Debt (Tables) HTML 33K
42: R31 Capital Stock (Tables) HTML 92K
43: R32 Accumulated Other Comprehensive Income (Tables) HTML 85K
44: R33 Earnings Per Share (Tables) HTML 38K
45: R34 Segment Information (Tables) HTML 144K
46: R35 Leases (Tables) HTML 67K
47: R36 Organization (Details) HTML 32K
48: R37 Basis of Presentation and Signficant Accounting HTML 42K
Policies Basis of Presentation and Significant
Acconting Policies (Details)
49: R38 Business Acquisitions Business Acquisition (Assets HTML 47K
Liabilities Acquired) (Details)
50: R39 Business Optimization Initiatives Narrative HTML 45K
(Details)
51: R40 Investments (Current And Long-Term Fixed Maturity HTML 92K
Securities, Available-For-Sale) (Details)
52: R41 Investments (Aggregate Fair Value And Gross HTML 76K
Unrealized Loss Of Fixed Maturity Securities In An
Unrealized Loss Position) (Details)
53: R42 Investments (Allowance For Credit Loss HTML 46K
Rollforward) (Details)
54: R43 Investments (Amortized Cost And Fair Value Of HTML 59K
Fixed Maturity Securities, By Contractual
Maturity) (Details)
55: R44 Investments (Proceeds and Realized Gains Losses HTML 34K
From Fixed Maturity Securities) (Details)
56: R45 Investments (Current and Long-term Equity HTML 37K
Securities) (Details)
57: R46 Investments (Gains and Losses Recognized on Equity HTML 35K
Securities) (Details)
58: R47 Investments (Securities Lending Programs) HTML 40K
(Details)
59: R48 Investments (Narrative) (Details) HTML 34K
60: R49 Derivative Financial Instruments (Financial HTML 32K
Statement Narrative) (Details)
61: R50 Fair Value (Fair Value Measurements By Level For HTML 147K
Assets Measured At Fair Value On A Recurring
Basis) (Details)
62: R51 Fair Value (Reconciliation Of The Beginning And HTML 77K
Ending Balances Of Assets Measured At Fair Value
On A Recurring Basis Using Level III Inputs)
(Details)
63: R52 Fair Value (Carrying And Estimated Fair Values by HTML 55K
Level Of Financial Instruments Not Recorded At
Fair Value On Consolidated Balance Sheet)
(Details)
64: R53 Income Taxes (Narrative) (Details) HTML 35K
65: R54 Retirement Benefits (Components Of Net Periodic HTML 53K
(Benefit Credit) Benefit Cost) (Details)
66: R55 Retirement Benefits (Narrative) (Details) HTML 28K
67: R56 Medical Claims Payable (Reconciliation Of The HTML 88K
Beginning And Ending Balances For Medical Claims
Payable By Segment) (Details)
68: R57 Medical Claims Payable (Reconciliation Of Net HTML 44K
Incurred Medical Claims To Benefit Expense)
(Details)
69: R58 Medical Claims Payable Medical Claims Payable HTML 50K
(Reconciliation of the Claims Development to the
Claims Liability) (Details)
70: R59 Medical Claims Payable (Narrative) (Details) HTML 46K
71: R60 Debt (Convertible Debenture Details) (Details) HTML 44K
72: R61 Debt (Narrative) (Details) HTML 106K
73: R62 Commitments And Contingencies (Details) HTML 56K
74: R63 Capital Stock (Summary of Cash Dividend Activity) HTML 38K
(Details)
75: R64 Capital Stock (Summary of Share Repurchases) HTML 38K
(Details)
76: R65 Capital Stock (Summary of Stock Option Activity) HTML 64K
(Details)
77: R66 Capital Stock (Nonvested Restricted Stock Activity HTML 52K
Including Restricted Stock Units) (Details)
78: R67 Capital Stock (Fair Values of Options Granted HTML 37K
During The Period Estimated Using Weighted-Average
Assumptions) (Details)
79: R68 Capital Stock (Schedule Of Weighted-Average Fair HTML 32K
Values Determined For The Periods) (Details)
80: R69 Capital Stock (Narrative) (Details) HTML 50K
81: R70 Accumulated Other Comprehensive Loss HTML 79K
(Reconciliation Of The Components Of Accumulated
Other Comprehensive Income) (Details)
82: R71 Accumulated Other Comprehensive Income (Other HTML 50K
Comprehensive Income (Loss) Reclassification
Adjustments) (Details)
83: R72 Accumulated Other Comprehensive Income (Loss) HTML 46K
Accumulated Other Comprehensive Income
Reclassification Adjustments (Details)
84: R73 Earnings Per Share (Denominator For Basic And HTML 34K
Diluted Earnings Per Share) (Details)
85: R74 Earnings Per Share (Narrative) (Details) HTML 34K
86: R75 Segment Information (Financial Data By Reportable HTML 62K
Segment) (Details)
87: R76 Segment Information Segment Information (Major HTML 56K
Product Revenues for Each Reportable Segment)
(Details)
88: R77 Segment Information (Reconciliation Of Reportable HTML 38K
Segments Operating Revenues To Total Revenues
Reported In The Consolidated Statements Of Income)
(Details)
89: R78 Segment Information (Reconciliation Of Reportable HTML 46K
Segments Operating Gain To Income Before Income
Tax Expense Included In The Consolidated
Statements Of Income) (Details)
90: R79 Segment Information Segment Information HTML 28K
(Narrative) (Details)
91: R80 Leases (Lease and Other Information) (Details) HTML 51K
92: R81 Leases (Reconciliation of Future Lease Payments to HTML 46K
Total Lease Liabilities) (Details)
93: R82 Leases (Narrative) (Details) HTML 48K
95: XML IDEA XML File -- Filing Summary XML 187K
11: XML XBRL Instance -- antm-20200930_htm XML 4.52M
94: EXCEL IDEA Workbook of Financial Reports XLSX 144K
7: EX-101.CAL XBRL Calculations -- antm-20200930_cal XML 279K
8: EX-101.DEF XBRL Definitions -- antm-20200930_def XML 1.17M
9: EX-101.LAB XBRL Labels -- antm-20200930_lab XML 2.52M
10: EX-101.PRE XBRL Presentations -- antm-20200930_pre XML 1.59M
6: EX-101.SCH XBRL Schema -- antm-20200930 XSD 250K
96: JSON XBRL Instance as JSON Data -- MetaLinks 503± 809K
97: ZIP XBRL Zipped Folder -- 0001156039-20-000089-xbrl Zip 480K
1.I have reviewed this report on Form 10-Q of Anthem, Inc.;
2.Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)disclosed in this report any change in the registrant’s
internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
